A Two-Faced MSWI/SNF Subunit: Dual Roles for ARID1A in Tumor Suppression and Oncogenicity in the Liver

Overview

Journal Cancer Cell

Publisher Cell Press

Specialty Oncology

Date 2017 Nov 15

PMID 29136498

Citations 9

Authors

Jordan E Otto

Cigall Kadoch

Affiliations

Soon will be listed here.

Abstract

In this issue of Cancer Cell, Sun et al. describe context-dependent oncogenic and tumor-suppressive functions for the mammalian SWI/SNF (BAF) complex subunit ARID1A in the development and progression of hepatocellular carcinoma (HCC).

Citing Articles

The stage-dependent prognostic role of in hepatocellular carcinoma.

Zhou H, Sun D, Miao C, Tao J, Ge C, Chen T Transl Cancer Res. 2023; 12(11):3088-3104.

PMID: 38130310 PMC: 10731336. DOI: 10.21037/tcr-23-645.

Prognostic biomarker SMARCC1 and its association with immune infiltrates in hepatocellular carcinoma.

Cai X, Zhou J, Deng J, Chen Z Cancer Cell Int. 2021; 21(1):701.

PMID: 34937564 PMC: 8697473. DOI: 10.1186/s12935-021-02413-w.

ARID1A deficiency weakens BRG1-RAD21 interaction that jeopardizes chromatin compactness and drives liver cancer cell metastasis.

Shang X, Shi Y, He D, Wang L, Luo Q, Deng C Cell Death Dis. 2021; 12(11):990.

PMID: 34689165 PMC: 8542038. DOI: 10.1038/s41419-021-04291-6.

ASF1B Promotes Oncogenesis in Lung Adenocarcinoma and Other Cancer Types.

Zhang W, Gao Z, Guan M, Liu N, Meng F, Wang G Front Oncol. 2021; 11:731547.

PMID: 34568067 PMC: 8459715. DOI: 10.3389/fonc.2021.731547.

alterations and their clinical significance in cholangiocarcinoma.

Namjan A, Techasen A, Loilome W, Sa-Ngaimwibool P, Jusakul A PeerJ. 2020; 8:e10464.

PMID: 33344089 PMC: 7719290. DOI: 10.7717/peerj.10464.